Klebsiella pneumoniae, a bacterium found in the gut, may reach the brain and affect Alzheimer's disease progression, research ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

Coya Therapeutics said on Tuesday its experimental Alzheimer's drug was safe and increased levels of a type of immune cells ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

The overall rate of emergency room visits for older adults with Alzheimer's disease was 36.1 visits per 1,000 adults in ...

As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

Alzheimer's disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University in ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.